. Author manuscript; available in PMC: 2022 Oct 1.

Published in final edited form as: J Neurointerv Surg. 2020 Oct 30;13(10):865–868. doi: 10.1136/neurintsurg-2020-016783

Table 2.

Outcomes after thrombectomy for patients with baseline modified Rankin Scale (mRS) dichotomized 0-1 vs 2-4.

	Baseline mRS 0-1	Baseline mRS 2-4	p
TICI 2b-3, Count (%)	260 (78%)	38 (78%)	0.855
ICH, Count (%)	23 (7%)	1 (2%)	0.340
Final Infarct Vol CC, Median (IQR)	45 (18-116)	68 (7-147)	0.828
90-Day Absolute mRS≤2, Count (%)	133 (45%)	6 (14%)	<0.0001
90-Day Mortality	55 (19%)	21 (50%)	<0.0001
90-Day Delta mRS≤0, Count (%)	48 (16%)	10 (24%)	0.272
90-Day Delta mRS≤1, Count (%)	100 (34%)	19 (45%)	0.168
90-Day Delta mRS=1, Count (%)	52 (18%)	9 (21%)	0.524
90-Day Delta mRS≤2, Count (%)	144 (49%)	23 (55%)	0.511
90-Day Delta mRS=2, Count (%)	44 (15%)	4 (10%)	0.480
90-Day Delta mRS=3, Count (%)	49 (17%)	10 (24%)	0.277
90-Day Delta mRS=4, Count (%)	37 (13%)	9 (21%)	0.145
90-Day Delta mRS=5, Count (%)	26 (8.8%)	0 (0.0%)	0.057

Abbreviations: TICI Thrombolysis in Cerebral Infarction, ICH intracerebral hemorrhage, CC cubic centimeters, IQR interquartile range.